Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Finished Goods (2019 - 2020)

Sunshine Biopharma's Finished Goods history spans 2 years, with the latest figure at $23771.0 for Q4 2020.

  • For Q4 2020, Finished Goods rose 49.41% year-over-year to $23771.0; the TTM value through Dec 2020 reached $23771.0, up 49.41%, while the annual FY2020 figure was $23771.0, 49.41% up from the prior year.
  • Finished Goods reached $23771.0 in Q4 2020 per SBFM's latest filing, up from $15910.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $23771.0 in Q4 2020 to a low of $15910.0 in Q4 2019.